118
Share prices of existing licensed producers responded favourably but will that translate into an uptick into the summer which historically is a downward period.
I want to build off of the underlining theme from my past articles whether in the Canadian or in the US edition and that theme has always been “quality”. It is a word that gets tossed around in this industry from everyone regardless of where their stake in the ground lies.
Those against the legalization of cannabis (including medical) remind us that:
the quality of clinical trials and research is just not there …
the absence of DINs infers medical cannabis is not medical grade or quality …
that two people buying the same strain could receive cannabis with differing profiles (cannabinoids, terpenes, etc) … these are concerns of quality …
and so forth …
Black market proponents often toss around unfounded statements suggesting that legal cannabis is of inferior quality to black market supply. Given the lack of proper testing of black market cannabis and that there has been genetic bottlenecking (preference given to higher THC strains) it is, in my opinion, an unfounded position without substance. Such a position possibly relies on anecdotal folklore and alternative facts.
Proponents of the legal framework remind us of the proven best in class Quality Assurance that exists in this industry (Canada in particular) that puts the safety of patients and consumers first.
Paid Promoters/Curators and Hobbyists may at times muddy the quality of investment information due to bias, filtering, and conflicts of interest whether in fact or in appearance. Note: I have never said you will lose money following paid promoters. I have only suggested that it is possible that some may have motives and goals that do not line up with your own and there may also be the potential for some paid promoters to filter and editorialize their finished products. I have also stated that it seems odd to me that they can print disclaimers that their content is not a recommendation when it is written for their paying client(s) in a favourable manner with an investment focus and has investors as the target audience.
•
150